Microsurgical treatment of temporal lobe cavernomas

Area of Science:

• Neurosurgery
• Neurology
• Epileptology

Background:

• Temporal lobe cavernomas represent 10-20% of cerebral cavernomas and frequently cause medically refractory epilepsy.
• Surgical intervention for symptomatic temporal lobe cavernomas is often considered for patients with good long-term outcomes.

Observation:

• This retrospective study analyzed 49 patients with single temporal lobe cavernomas treated surgically.
• Cavernomas were categorized by location: medial, anterolateral, and posterolateral.
• Follow-up data were collected via phone interviews, assessing seizure control (Engel classification) and general outcome (Glasgow Outcome Scale).

Findings:

• 82% of patients experienced epileptic seizures preoperatively.
• Postoperative follow-up (median 6 years) showed favorable seizure outcomes (Engel class I and II) in 90% of patients.
• 96% of patients achieved good general outcomes (GOS 4.5), with only 4% experiencing new or worsened memory deficits.

Implications:

• Microsurgical resection of temporal lobe cavernomas is a safe and effective treatment for intractable epilepsy.
• Surgical removal can prevent neurological deterioration associated with cavernoma hemorrhage.
• This approach offers significant seizure relief and improves overall quality of life for affected individuals.